PT-2385 Uses, Dosage, Side Effects and more
PT-2385 is under investigation in clinical trial NCT03108066 (PT2385 for the Treatment of Von Hippel-lindau Disease-associated Clear Cell Renal Cell Carcinoma).
| Trade Name | PT-2385 |
| Generic | PT-2385 |
| Type | |
| Formula | C17H12F3NO4S |
| Weight | Average: 383.34 Monoisotopic: 383.043913533 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
